Company intelligence / Profile preview

Spirax

San Luis Obispo, California, United States

Ownership: Private
Development stage: Other

Overview

Spirax is a medical technology company that specializes in the development of minimally invasive solutions for lumbar spinal stenosis (LSS). The company's flagship technology is a tissue-sparing, non-fusion implant designed to treat patients with neurogenic claudication by providing decompression without the need for extensive bone or ligament removal. This approach offers a middle-ground treatment option between conservative management and traditional invasive spinal surgery. In 2024, Spirax was acquired by Stryker, integrating its innovative spinal technology into Stryker’s Interventional Spine business unit.

Therapeutic areas: Neurology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Spirax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spirax.

Explore the full profile